HEMI
发表于 2025-3-21 19:45:29
书目名称New Antimicrobials: For the Present and the Future影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0664778<br><br> <br><br>书目名称New Antimicrobials: For the Present and the Future影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0664778<br><br> <br><br>书目名称New Antimicrobials: For the Present and the Future网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0664778<br><br> <br><br>书目名称New Antimicrobials: For the Present and the Future网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0664778<br><br> <br><br>书目名称New Antimicrobials: For the Present and the Future被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0664778<br><br> <br><br>书目名称New Antimicrobials: For the Present and the Future被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0664778<br><br> <br><br>书目名称New Antimicrobials: For the Present and the Future年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0664778<br><br> <br><br>书目名称New Antimicrobials: For the Present and the Future年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0664778<br><br> <br><br>书目名称New Antimicrobials: For the Present and the Future读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0664778<br><br> <br><br>书目名称New Antimicrobials: For the Present and the Future读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0664778<br><br> <br><br>
CUR
发表于 2025-3-22 00:17:59
http://reply.papertrans.cn/67/6648/664778/664778_2.png
天赋
发表于 2025-3-22 02:05:09
I. W. Fonger Querschnittsschwerpunkte ersetzt. .• Es wird vorausgesetzt, dass alle Einwirkungen zeitlich unveränderlich sind, so dass keine dynamischen Effekte auftreten. .• Bei der Formulierung des Gleichgewichts werden die Tragwerksverformungen als vernachlässigbar klein angenommen, d. h. es wird nach der T
独行者
发表于 2025-3-22 06:32:10
Antimicrobial Resistance: A Crisis in the Making,sistant .) and malaria (artemisinin-resistant .), certain viral infections (cytomegalovirus and human immunodeficiency virus), and specific fungal opportunistic pathogens (. and . sp.)..It is estimated that 700,000 deaths occur yearly in the world from AMR infections and projected to escalate to ten
creatine-kinase
发表于 2025-3-22 12:19:24
New Glycopeptides: Telavancin, Dalbavancin, and Oritavancines to meet the unmet needs. These new agents, telavancin, dalbavancin, and oritavancin, are more potent and have superior pharmacokinetic profile than the first-generation glycopeptides (vancomycin and teicoplanin). This chapter discusses these new semisynthetic agents’ in vitro activity, pharmacolo
虚度
发表于 2025-3-22 16:25:48
New Tetracyclines: Eravacycline and Omadacyclinea-abdominal infections and omadacycline for community-acquired pneumonia and acute bacterial skin and soft tissue infections. This chapter reviews their chemical structure, pharmacokinetic and pharmacodynamics parameters, microbial activity, ease of resistance, clinical efficacy, adverse effects, an
配置
发表于 2025-3-22 17:25:50
http://reply.papertrans.cn/67/6648/664778/664778_7.png
讲个故事逗他
发表于 2025-3-22 23:15:57
New Antiviral Agent for Influenza: Baloxaviroral antiviral, baloxavir, was approved in the United States for influenza infection. This chapter reviews the chemistry, antiviral activity, pharmacokinetics, efficacy, and side effects of baloxavir.
恶意
发表于 2025-3-23 04:30:55
Book 2023for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparis
dandruff
发表于 2025-3-23 09:28:12
http://reply.papertrans.cn/67/6648/664778/664778_10.png